XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Operating activities      
Net loss $ (12,159,174) $ (36,350,790) $ (19,588,762)
Adjustments to reconcile net loss to net cash used in operating activities:      
Accretion expense 6,584 12,671 294,000
Amortization and depreciation of equipment and intangible assets 18,436 157,760 985,895
Amortization of right-of-use assets   185,053 421,984
Change in unrealized gains/losses on warrant liabilities (131,250) 73,885  
Common shares issued for services 115,500 1,351,808 185,129
Financial guarantee liability 901,095 182,200  
Foreign exchange loss (gain) 238,206 (39,050) (11,085)
Gain on debt modification (56,264)    
Gain (loss) on sale/abandonment of assets, net   (804,429) 1,303,278
Loss on impairment of equipment     3,901
Loss on impairment of intangible assets   12,116,908 6,625,246
Other income - premium on loans payable (50,949)    
Share-based payments 1,231,400 826,632 1,597,655
Unidentifiable assets acquired   16,666,666  
Changes in working capital accounts:      
Amounts receivable (181,029) (349,896) (92,879)
Prepaids and other current assets 10,288 (269,998) 10,415
Deposit     (177,300)
Accounts payable and accrued liabilities (1,157,595) (993,932) 1,050,328
Due to related parties (516,793) 69,631 (329,446)
Income tax payable 166,667    
Deferred revenue     (159,000)
Net cash used in operating activities (11,202,820) (7,164,881) (7,880,641)
Investing activities      
Acquisition obligation     (432,923)
Cash acquired through acquisitions   25,065  
Loans receivable, net     (165,428)
Purchase of property and equipment   (10,153) (542,742)
Purchase of intangible assets   (86,462)  
Net cash used in investing activities   (71,550) (1,141,093)
Financing activities      
Lease payments   (499,929) (559,580)
Payment for debt modification     (250,000)
Proceeds from (repayment of) convertible debenture (250,000) 600,000 (3,250,000)
Proceeds from exercise of warrants   189,600  
Proceeds from issuance of common shares and warrants, net 11,440,705 1,289,343 16,310,000
Proceeds from issuance of special warrants, net   2,510,630  
Repayment of loan payable 120,000    
Repayment of promissory note     (24,000)
Shelf prospectus transaction costs (77,184)    
Net cash provided by financing activities 11,233,521 4,089,644 12,226,420
Effects of exchange rate changes on cash (11,910) 19,805 2,218
Net change in cash 18,791 (3,126,982) 3,206,904
Cash - beginning of period 154,722 3,281,704 74,800
Cash - end of period $ 173,513 $ 154,722 $ 3,281,704